Carl P. Griffin, M.D.November 17, 2023

FDA 483 - Carl P. Griffin, M.D. - November 17, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Carl P. Griffin, M.D.

Record Details

An FDA inspection of Carl F. Griffin, M.D. in Oklahoma City, a clinical investigator, revealed a significant issue regarding the conduct of an investigation. Specifically, the firm failed to properly review, verify, and evaluate subject diary entries for unsolicited Adverse Events as required by the investigational plan and protocol. This indicates a lapse in adherence to established research procedures.

Company: Carl P. Griffin, M.D.
Inspection Date: November 17, 2023
Product Type: Drugs
Office: Division of Human and Animal Food Operations - West III
People: Terri E. Gibson
Habacuc V. Barrera

Open in Dashboard

ID · 5e0fa7fa-807e-46ab-adf9-1b020127934d